Evidence-based wearable Theranica will be offered to members covered under the Harvard Pilgrim Health Plan and Tufts Health Plan
Montclair, New Jersey And the Canton, Massachusetts.And the October 24, 2022 /PRNewswire/- Theranicaa prescription digital therapy company that is developing advanced digitally connected neuromodulators for migraines and other pain conditions, announced today that it has teamed up with Point32 Healththe parent organization of Harvard Pilgrim Health Care and Tufts Health Plan, to conduct a 12-month trial aimed at treating commercial organization members with episodic and chronic migraines.
“Point32Health understands the importance of providing its members with effective, advanced solutions to improve their quality of life,” said Alon IronCEO of Theranica. “We are committed to making Nerivio accessible to people with migraines who are looking for cost-effective, chemical-free treatments to manage this debilitating disease. We look forward to working with Point32Health and with healthcare providers participating in this pilot program, and to establishing additional strategic collaborations to ensure widespread access to this disruptive technology treatment. “
Nerivio is a non-invasive, drug-free, FDA-approved wearable device for the treatment of episodic and chronic migraines in people 12 years of age or older. Uniquely worn on the upper arm at the onset of a migraine attack, Nerivio relieves migraine headaches and associated symptoms through the use of remote electrical nerve modulation to trigger an endogenous analgesic mechanism, known as conditioned pain modulation. The device can be used as a standard for a pharmacological option of care, as a stand-alone treatment or in combination with existing therapies.
“Migraines affect more than 10 percent of the population, and cause significant discomfort that negatively impacts their quality of life,” he said. Michael ShermanMD, MBA, MSc, Executive Vice President and Chief Medical Officer at Point32Health. “We are excited to work with Theranica to offer Nerivio as a drug-free solution for our members who suffer from severe migraines and frequent attacks. This pilot highlights our commitment to providing access to a wide range of medical devices and tools that support healthy living.”
Eligible Harvard Pilgrim And the tufts Members of New England health plans should discuss enrollment in the program with neurologists. Participating neurologists will prescribe Nerivio for eligible Harvard Pilgrim Health Care and Tufts Health Plan members, including Tufts Health Direct members.
“Many of my patients have found Nerivio to be very effective for them,” he said Ashina websiteMD, assistant professor of neurology and headache specialist at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. “Given the multifaceted complexity of migraines, it is essential that patients have access to a wide range of treatments, both pharmacological and drug-free. A large portion of the patients in my clinic are Point32Health members, and I appreciate that they now have access to this important treatment.”
Point32Health is a leading health and wellness organization, providing a better healthcare experience for everyone in our communities. Building on the quality nonprofit heritage of our founding organizations, the Tufts Health Plan and Harvard Pilgrim Health Care, we leverage our expertise and experience to help people find their version of healthy living through a wide range of health plans and tools that make health and wellness navigate. Luxury is easier.
Our programs take a 360-degree view of health for our members – regardless of their age, health, race, identity or income. Our Institute works to improve the health of the population – and our Foundation works with communities to support, advocate and promote healthy lives for all. We use empathy to understand what is important to those we serve, and always make their priorities our priority. We guide and empower people by bringing together broad-based partners and perspectives to create new approaches that make a real difference to our community, industry and our 2.2 million members across New England.
Theranica is a digital prescription therapy company dedicated to creating effective, safe, affordable, and low-side-effect treatments for idiopathic pain conditions. The company’s flagship award-winning product, Nerivio®, is the first FDA-prescribed smartphone-controlled wearable device for acute migraine treatment, and has recently surpassed a quarter of a million treatments performed to date. Theranica is expanding its proprietary technology to develop solutions for additional idiopathic pain conditions. Nerivio is FDA approved and CE marked for use in the acute treatment of episodic and chronic migraine headaches in adult and adolescent patients.
Source Point 32 Health